Kuhlen Christian V 4
4 · GENOPTIX INC · Filed Mar 7, 2011
Insider Transaction Report
Form 4
GENOPTIX INCGXDX
Kuhlen Christian V
VP, Gen Counsel & Sec
Transactions
- Disposition to Issuer
Common Stock
2011-03-07$25.00/sh−3,283$82,075→ 98 total - Disposition to Issuer
Employee Stock Option (right to buy)
2011-03-07$15.97/sh−3,071$49,044→ 0 totalExercise: $9.03Exp: 2017-09-11→ Common Stock (3,071 underlying)
Footnotes (3)
- [F1]Represents unvested RSUs outstanding immediately prior to the closing of the merger of GO Merger Sub, Inc. ("GO") with and into the Issuer on March 7, 2011 (the "Merger") pursuant to the Agreement and Plan of Merger, dated January 24, 2011 among the Issuer, GO and Novartis Finance Corporation (the "Merger Agreement") that were converted into an award of RSUs that is subject to the same terms and conditions as were applicable to the RSUs prior to the Merger, except that, upon the vesting of such awards the reporting person will be issued the number of shares of Novartis AG as traded on the NYSE pursuant to the formula set forth in the Merger Agreement.
- [F2]Includes 98 shares acquired under the Genoptix employee stock purchase plan on March 4, 2011.
- [F3]This option was terminated in the Merger and exchanged into the right to receive in cash the amount per share by which $25.00 exceeds the exercise price of the option, subject to any applicable tax withholdings.